Αποτελέσματα Αναζήτησης
1 Μαΐ 2018 · Visit our Patient Assistance page and click the links to various patient assistance programs for help paying for Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®). Depending upon your income, they may be able to help cover the cost of:
The protocol cost is derived from drug dose calculations based upon a default body surface area (BSA) of 1.8 m 2; weight of 75 kg; and creatinine clearance of 75 mL/min. One off loading doses and ongoing maintenance doses are not included in protocol cost calculations.
7 Δεκ 2022 · The following material represents a subset of chemotherapy and immunotherapy regimens that are used for the treatment of patients with breast cancer, both in the adjuvant and neoadjuvant settings.
The protocol cost is derived from drug dose calculations based upon a default body surface area (BSA) of 1.8 m 2; weight of 75 kg; and creatinine clearance of 75 mL/min. One off loading doses and ongoing maintenance doses are not included in protocol cost calculations.
14 Δεκ 2023 · This topic review will cover the use of adjuvant HER2-directed therapy plus chemotherapy in patients with HER2-positive, early-stage breast cancer (stage I to III).
Treatment overview. This treatment regimen consists of two parts: 4 cycles of AC, followed by 4 cycles of TH and 13 cycles of trastuzumab. Breast neoadjuvant/adjuvant AC (DOXOrubicin and CYCLOPHOSPHamide) three weekly. Breast adjuvant TH (DOCEtaxel and trastuzumab) three weekly.
26 Απρ 2016 · Adjuvant Regimen When an Anthracycline Is Not Preferred. Docetaxel plus cyclophosphamide (TC) × 4 is recommended as an alternative to AC × 4 and offers improved disease-free survival (DFS) and overall survival (OS). Classic CMF with oral cyclophosphamide for six cycles is another option.
